Volume surge: ViewRay (6L9.F XETRA) €0.025 25 Feb 2026 Closed: liquidity watch
A large intraday volume spike drove ViewRay, Inc. (6L9.F) to €0.025 on 25 Feb 2026, marking a 12.54x jump in relative volume as XETRA trading closed. The move puts the healthcare device name in our high-volume movers list and forces a closer look at liquidity, short-term technicals, and valuation. Traders should note the tiny float price action against a market cap of €207,228,256.00 and weigh volatility against fundamentals before acting.
6L9.F stock market snapshot and volume context
Today ViewRay, Inc. (6L9.F) closed on XETRA at €0.025 with 3,500 shares traded versus an average volume of 279. The relative volume of 12.5448 points to outsized interest in a usually thinly traded listing. The one‑month return shows a sharp bounce of 2,400.00% from last month’s low trading levels, but the stock remains -95.28% versus the three‑month average price trend.
Why the high volume moved the price
A liquidity-driven spike often reflects concentrated buys or short-covering in low‑priced stocks; today’s open at €0.001 and close at €0.025 suggests aggressive intraday orders. With a day high of €0.025 and day low of €0.001, the range is extreme and shows order-book thinness. For short-term traders, the volume surge is the primary driver of price action rather than fresh earnings or guidance.
Fundamentals and valuation for ViewRay, Inc. (6L9.F)
ViewRay operates in Medical – Devices and reports trailing EPS of -0.55 and a negative PE ratio of -0.05, reflecting losses. Key ratios include a price-to-sales of 2.39, price-to-book of 0.06, and current ratio of 2.36, indicating a solid short-term liquidity position. The company’s book value per share is €0.46, and cash per share is €0.75, which helps explain investor interest despite operating losses.
Technical profile, moving averages and trading signals
Price averages are well above the current quote, with the 50‑day at €0.32 and 200‑day at €2.72, indicating a long-term downtrend. The intra‑day jump to €0.025 is a mean-reversion candidate for traders looking at momentum, but the wide gap to historical averages raises risk of rapid retracement. Watch for follow-through volume above 5,000 shares to confirm a sustained breakout.
Meyka AI rates 6L9.F with a score out of 100 and model forecast
Meyka AI rates 6L9.F with a score out of 100: 61.46 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a reference target of €0.080, implying an upside of 220.00% versus the current €0.025. Forecasts are model-based projections and not guarantees.
Risks and opportunities for investors and traders
Opportunity exists if buyers sustain volume and narrow the gap toward 50‑day average; the healthcare sector’s steady demand for MR‑guided radiotherapy supports long-term interest. Risk elements include negative operating margins, interest coverage of -21.18, debt-to-equity of 1.05, and high price volatility from low float. Position sizing and stop-loss discipline are essential for exposure to 6L9.F stock.
Final Thoughts
High intraday volume pushed ViewRay, Inc. (6L9.F) to €0.025 on XETRA as the market closed on 25 Feb 2026. The move was clearly liquidity-driven: volume was 3,500 against an average 279, creating a short-term tradeable situation but not yet a structural reversal. Fundamentals show cash per share of €0.75, book value per share of €0.46, and trailing EPS of -0.55, so the company remains loss-making even as interest rises. Meyka AI’s forecast model projects €0.080, an implied upside of 220.00% versus today’s price; forecasts are model-based projections and not guarantees. Our view: the stock is a speculative, high‑volatility candidate for short-term trading on confirmed volume continuation, while longer-term investors should await clearer revenue and margin improvement. For quick reference, see ViewRay news and filings for catalysts and read our platform’s live data on the 6L9.F Meyka stock page for updates
FAQs
What caused the 6L9.F stock spike today?
The spike in 6L9.F stock was driven by a liquidity surge and concentrated intraday buying, with volume of 3,500 versus average 279, not by a fresh earnings release. Thin order books amplified the price move.
Is 6L9.F stock a buy after the volume surge?
After the surge, 6L9.F stock is speculative. Meyka AI gives a B (61.46) grade with a HOLD suggestion. Traders may consider short-term setups on confirmed follow-through volume; long-term buyers should wait for margin improvement.
What is Meyka AI’s forecast for 6L9.F stock?
Meyka AI’s forecast model projects a reference target of €0.080 for 6L9.F stock, implying 220.00% upside versus €0.025. Forecasts are model-based projections and not guarantees.
What key metrics should I watch for 6L9.F stock?
Monitor daily volume, follow-through above 5,000 shares, cash per share (€0.75), EPS trend, and any operational guidance or order announcements, as these will drive price and sentiment for 6L9.F stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.